Serimmune announced it raised $10.6 Million in an amended filing from an offering of $15 Million

Company

Location

About

Serimmune is an immune intelligence company that provides a holistic view of immunity to identify environmental factors in disease and health. The unique information we provide fuels development of new diagnostics, vaccines, and therapeutics. Founded in 2014, and backed by investors including Illumina Ventures, LabCorp, and Merck, Serimmune is developing new approaches for preventing, diagnosing, and treating a range of diseases.